Abstract
To determine the risk of neuropsychiatric adverse events associated with use of varenicline compared with placebo in randomised controlled trials. Systematic review and meta-analysis comparing study effects using two summary estimates in fixed effects models, risk differences, and Peto odds ratios. Medline, Embase, PsycINFO, the Cochrane Central Register of Controlled Trials (CENTRAL), and clinicaltrials.gov. Randomised controlled trials with a placebo comparison group that reported on neuropsychiatric adverse events (depression, suicidal ideation, suicide attempt, suicide, insomnia, sleep disorders, abnormal dreams, somnolence, fatigue, anxiety) and death. Studies that did not involve human participants, did not use the maximum recommended dose of varenicline (1 mg twice daily), and were cross over trials were excluded. In the 39 randomised controlled trials (10,761 participants), there was no evidence of an increased risk of suicide or attempted suicide (odds ratio 1.67, 95% confidence interval 0.33 to 8.57), suicidal ideation (0.58, 0.28 to 1.20), depression (0.96, 0.75 to 1.22), irritability (0.98, 0.81 to 1.17), aggression (0.91, 0.52 to 1.59), or death (1.05, 0.47 to 2.38) in the varenicline users compared with placebo us...Continue Reading
Citations
Nov 8, 2015·BMJ Open·Neil M DaviesMarcus R Munafò
Nov 19, 2015·Alcoholism, Clinical and Experimental Research·Henri-Jean Aubin, Amandine Luquiens
Oct 20, 2015·The Lancet. Respiratory Medicine·Frank T Leone, Robert Schnoll
Nov 14, 2015·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Ray Niaura
Nov 26, 2015·Addiction·Emmert RobertsDebbie Robson
Apr 3, 2016·American Journal of Preventive Medicine·Marian JarlenskiYuting Zhang
Apr 6, 2016·The American Journal of Medicine·Jason H SzostekKaren F Mauck
Sep 21, 2015·American Heart Journal·Sarah B WindleMark J Eisenberg
Jul 5, 2015·Drug and Alcohol Dependence·Li-Shiun ChenLaura J Bierut
Apr 28, 2016·Lancet·Robert M AnthenelliA Eden Evins
Apr 28, 2016·Lancet·Laurie Zawertailo
May 29, 2016·The Medical Clinics of North America·Jared Wilson Klein
May 24, 2016·La Presse médicale·Alain Dervaux, Xavier Laqueille
Jan 31, 2016·Addiction·Francesca E CunninghamChester B Good
Jun 9, 2016·Expert Opinion on Pharmacotherapy·Jose L BarbozaKaren Suchanek Hudmon
Jun 17, 2016·Expert Opinion on Drug Safety·Paolo Preziosi
Apr 5, 2016·Addiction·Qi WuSteve Parrott
Jul 30, 2016·Alcoholism, Clinical and Experimental Research·Janice C FroehlichLogan C Rademacher
Dec 19, 2015·The Lancet. Respiratory Medicine·Neil M DaviesKyla H Thomas
Sep 23, 2016·PloS One·Hayato AkimotoDaisuke Kobayashi
Oct 21, 2016·Addiction·Neil M Davies, Kyla H Thomas
Jun 2, 2017·PloS One·David F ZeiglerChristopher H Clegg
Jun 9, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Joel Monárrez-EspinoJette Möller
Dec 20, 2016·Annual Review of Public Health·Judith J ProchaskaKelly C Young-Wolff
Oct 27, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Freda PattersonDavid G Edwards
Dec 21, 2017·American Journal of Respiratory and Critical Care Medicine·Andrea S GershonPeter Selby
Sep 10, 2017·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·David Crockford, Donald Addington
Feb 21, 2018·Addiction·Neil M DaviesKyla H Thomas
Jan 18, 2017·Circulation. Cardiovascular Quality and Outcomes·Karine SuissaKristian B Filion
Nov 13, 2018·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Duygu İlke YıldırımMehmet Ali Eryılmaz
Jun 19, 2017·BMJ Open·Kyla H ThomasNicky J Welton
Dec 13, 2019·Journal of Psychopharmacology·Thomas Re BarnesAlison R Yung
Feb 14, 2020·Current Medical Research and Opinion·Serena TonstadCristina Russ
Jul 11, 2019·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Gemma M J TaylorAmy E Taylor
May 10, 2016·The Cochrane Database of Systematic Reviews·Kate CahillTim Lancaster
Aug 7, 2017·British Journal of Pharmacology·S A StuartE S J Robinson
Dec 29, 2017·The American Journal on Addictions·Jill M Williams
Feb 23, 2020·Addiction·Greg CarneyColin R Dormuth
Apr 13, 2020·HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues·Connor K Kianpour
Jun 5, 2020·Tobacco Induced Diseases·Shuilian ChuZhaohui Tong
Jun 11, 2017·NPJ Primary Care Respiratory Medicine·O C P Van SchayckA Ostrem
Mar 25, 2020·Pharmacological Reviews·M J MoerkeJ L Wilkerson
Dec 22, 2019·Scientific Reports·Taha ItaniAmy E Taylor
Nov 11, 2020·Expert Review of Respiratory Medicine·Katerina ByanovaLaurence Huang
Nov 17, 2020·Addiction·Kyla H ThomasIan Douglas
Jan 20, 2021·JAMA : the Journal of the American Medical Association·Carrie D PatnodeRachel G Thomas
Sep 2, 2017·Neuroscience and Biobehavioral Reviews·Jason A GandelmanWarren D Taylor
Apr 23, 2021·Addiction·Emma BeardRobert West
May 27, 2021·BMJ Open·Yuanyuan WangEelko Hak
Aug 3, 2021·British Journal of Hospital Medicine·Gideon KatzenbergJørgen Vestbo